AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 21-A-09-107.03
To strengthen program safeguards for preventing and detecting improper payments for drug testing services and to address the three specific…
The recommendation, in the publisher's words
To strengthen program safeguards for preventing and detecting improper payments for drug testing services and to address the three specific weaknesses we identified in this report, we recommend that the Centers for Medicare & Medicaid Services work with its Medicare contractors to implement a system edit or procedure to identify and limit the frequency of drug testing services per beneficiary across all Medicare jurisdictions. System edits or procedures that CMS and its contractors could consider include (1) adding a modifier to claims that represents the number of days of abstinence to track frequency or (2) determining the number of reasonable and necessary drug tests per calendar year per beneficiary and performing postpayment reviews of those tests that exceed the number.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- June 8, 2021
- Report
- Opportunities Exist for CMS and Its Medicare Contractors To Strengthen Program Safeguards To Prevent and Detect Improper Payments for Drug Testing Services (A-09-20-03017) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Non-Concur (as recorded by the publisher)
- Closed
- October 27, 2021 (publisher's date)
- Publisher topics
- Laboratories, Substance Abuse Disorder
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Unimplemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
4 more, of which 0 are open in the publisher's file.
- To strengthen program safeguards for preventing and detecting improper payments for drug testing services and to address the three specific weaknesses we identified in this report, we…HHS OIG 21-A-09-107.01 · issued Jun 8, 2021 · closed Oct 27, 2021Closed Unimplemented
- To strengthen program safeguards for preventing and detecting improper payments for drug testing services and to address the three specific weaknesses we identified in this report, we…HHS OIG 21-A-09-107.02 · issued Jun 8, 2021 · closed Oct 27, 2021Closed Unimplemented
- To strengthen program safeguards for preventing and detecting improper payments for drug testing services and to address the three specific weaknesses we identified in this report, we…HHS OIG 21-A-09-107.04 · issued Jun 8, 2021 · closed Dec 9, 2022Closed Implemented
- To strengthen program safeguards for preventing and detecting improper payments for drug testing services and to address the three specific weaknesses we identified in this report, we…HHS OIG 21-A-09-107.05 · issued Jun 8, 2021 · closed Dec 9, 2022Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.